Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk (201102127)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Washington University School of Medicine
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01104220
First received: April 13, 2010
Last updated: September 6, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)